Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line.
about
Toxicity evaluations of nanoclays and thermally degraded byproducts through spectroscopical and microscopical approachesSystematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsClay enriched silk biomaterials for bone formation.Haemolytic activity of soil from areas of varying podoconiosis endemicity in Ethiopia.Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-cultureClay: new opportunities for tissue regeneration and biomaterial design.Toxic effects of a modified montmorillonite clay on the human intestinal cell line Caco-2.In vitro toxicity of functionalised nanoclays is mainly driven by the presence of organic modifiers.Effect of Clinoptilolite and Sepiolite Nanoclays on Human and Parasitic Highly Phagocytic Cells.Use of nanoclay platelets in food packaging materials: technical and cytotoxicity approach.Novel Hydrogel-Advanced Modified Clay Nanocomposites as Possible Vehicles for Drug Delivery and Controlled Release.Effect of the solvent on the size of clay nanoparticles in solution as determined using an ultraviolet-visible (UV-Vis) spectroscopy methodology.In vivo toxicity evaluation of the migration extract of an organomodified clay-poly(lactic) acid nanocomposite.Nanoclay migration from food packaging materials.In vitro study of interactions between silicon-containing nanoparticles and human peripheral blood leukocytes.In Vivo Evaluation of Activities and Expression of Antioxidant Enzymes in Wistar Rats Exposed for 90 Days to a Modified ClayComparative Sustainability Assessment of Starch Nanocrystals
P2860
Q27908453-258A234D-2A58-4E70-B9F9-9AEE4A69A172Q28387541-9DF23928-1FD3-4BD2-97EA-7B858DF75B31Q35085663-D76A35B0-C222-44DF-B901-7C2352EA3B41Q36369024-4EB285E1-3F98-41BE-B63A-891526725631Q37213510-E8DF2BEB-8660-4641-93FF-9789D781AD55Q38110691-814F7145-63C2-4AE2-B1EF-4F677C0377E8Q39079587-DD9A57D0-E26B-4BEF-907A-90F21D3E9BBBQ39195152-CE50E806-095D-4D1D-9D29-CCF2FB52608CQ41560765-506EE1FE-AA23-4328-8EF5-5209AF98C514Q42450795-626E5590-007B-4809-B525-6DF38C64A940Q47161758-C5D84C74-5457-4D50-B842-9C4964A09FBAQ47388581-1B3EA8D1-8F93-4518-91D7-6D49F896739BQ50683535-720B5FF2-1006-45B6-B5DB-17C6B61B3E47Q53214433-F5FCD9F4-DE13-4457-8476-1040F547B299Q54733901-4D5E3C7F-5376-4622-9E37-90CC4C0C9680Q57615895-4FA920B8-843D-40ED-B428-3F7E84B1D610Q58216826-F3DF8083-4A21-42B7-A5F3-45A0F29CD26C
P2860
Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cytotoxic effects induced by u ...... human hepatic HepG2 cell line.
@en
Cytotoxic effects induced by u ...... human hepatic HepG2 cell line.
@nl
type
label
Cytotoxic effects induced by u ...... human hepatic HepG2 cell line.
@en
Cytotoxic effects induced by u ...... human hepatic HepG2 cell line.
@nl
prefLabel
Cytotoxic effects induced by u ...... human hepatic HepG2 cell line.
@en
Cytotoxic effects induced by u ...... human hepatic HepG2 cell line.
@nl
P356
P1476
Cytotoxic effects induced by u ...... human hepatic HepG2 cell line
@en
P2093
Clement L Higginbotham
James E Kennedy
P2860
P356
10.1002/JAT.1564
P407
P577
2011-01-01T00:00:00Z